Recombinant adenoviruses have broad applications for gene delivery and expression. Furthermore, the adenovirus packaging system facilitates the expression of RNA-guided CRISPR/Cas9 nuclease complexes. In this study, we developed a novel system, named AdBlue, for the construction of recombinant adenoviruses using an enzymatic assembly strategy. This system could significantly reduce the time and labor required to generate adenoviral vectors. When applied to CRISPR/Cas9 design, it simplifies the preparation of recombinant adenoviruses carrying nuclease complexes and can induce high levels of site-specific mutagenesis. Our system has outstanding advantages for adenovirus preparation and could be a useful molecular engineering tool for gene delivery and editing.
Get full access to this article
View all access options for this article.
References
1.
LuoJ, DengZL, LuoX, et al.A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc. 2007; 2:1236–1247. DOI: 10.1038/nprot.2007.135.
2.
CortinV, ThibaultJ, JacobD, et al.High-titer adenovirus vector production in 293S cell perfusion culture. Biotechnol Prog. 2004; 20:858–863. DOI: 10.1021/bp034237l.
3.
TakehashiM, Kanatsu-ShinoharaM, InoueK, et al.Adenovirus-mediated gene delivery into mouse spermatogonial stem cells. Proc Natl Acad Sci U S A. 2007; 104:2596–2601. DOI: 10.1073/pnas.0609282104.
4.
KottermanMA, ChalbergTW, SchafferDV. Viral vectors for gene therapy: translational and clinical outlook. Annu Rev Biomed Eng. 2015; 17:63–89. DOI: 10.1146/annurev-bioeng-071813-104938.
5.
YinH, SongCQ, DorkinJR, et al.Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat Biotechnol. 2016; 34:328–333. DOI: 10.1038/nbt.3471.
6.
ZurisJA, ThompsonDB, ShuY, et al.Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol. 2015; 33:73–80. DOI: 10.1038/nbt.3081.
7.
MaggioI, HolkersM, LiuJ, et al.Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells. Sci Rep. 2014; 4:5105. DOI: 10.1038/srep05105.
8.
HolkersM, MaggioI, HenriquesSF, et al.Adenoviral vector DNA for accurate genome editing with engineered nucleases. Nat Methods. 2014; 11:1051–1057. DOI: 10.1038/nmeth.3075.
9.
DingQ, StrongA, PatelKM, et al.Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing. Circ Res. 2014; 115:488–492. DOI: 10.1161/circresaha.115.304351.
TanR, LiC, JiangS, et al.A novel and simple method for construction of recombinant adenoviruses. Nucleic Acids Res. 2006; 34:e89. DOI: 10.1093/nar/gkl449.
12.
HeTC, ZhouS, da CostaLT, et al.A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A. 1998; 95:2509–2514. DOI: 10.1073/pnas.95.5.2509.
13.
JagerL, HauslMA, RauschhuberC, et al.A rapid protocol for construction and production of high-capacity adenoviral vectors. Nat Protoc. 2009; 4:547–564. DOI: 10.1038/nprot.2009.4.
14.
RanFA, HsuPD, WrightJ, et al.Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013; 8:2281–2308. DOI: 10.1038/nprot.2013.143.
15.
DoudnaJA, CharpentierE. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science (New York, NY)., 2014; 346:1258096. DOI: 10.1126/science.1258096.
16.
GibsonDG, YoungL, ChuangRY, et al.Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009; 6:343–345. DOI: 10.1038/nmeth.1318.
17.
GibsonDG, SmithHO, HutchisonCA, 3rd et al. Chemical synthesis of the mouse mitochondrial genome. Nat Methods. 2010; 7:901–903. DOI: 10.1038/nmeth.1515.
18.
TangY, WangH, WeiB, et al.CUG-BP1 regulates RyR1 ASI alternative splicing in skeletal muscle atrophy. Sci Rep. 2015; 5:16083. DOI: 10.1038/srep16083.
19.
HessGT, TyckoJ, YaoD, et al.Methods and applications of CRISPR-mediated base editing in eukaryotic genomes. Mol Cell. 2017; 68:26–43. DOI: 10.1016/j.molcel.2017.09.029.
20.
BolukbasiMF, GuptaA, WolfeSA. Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery. Nat Methods. 2016; 13:41–50. DOI: 10.1038/nmeth.3684.
21.
GrahamFL, SmileyJ, RussellW, et al.Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977; 36:59–72. DOI: 10.1099/0022-1317-36-1-59.
22.
GibsonDG, GlassJI, LartigueC, et al.Creation of a bacterial cell controlled by a chemically synthesized genome. Science (New York, NY). 2010; 329:52–56. DOI: 10.1126/science.1190719.
23.
NellesDA, FangMY, O'ConnellMR, et al.Programmable RNA tracking in live cells with CRISPR/Cas9. Cell. 2016; 165:488–496. DOI: 10.1016/j.cell.2016.02.054.
24.
Mück-HäuslM, SolankiM, ZhangW, et al.Ad 2.0: A novel recombineering platform for high-throughput generation of tailored adenoviruses. Nucleic Acids Res. 2015; 43:e50. DOI: 10.1093/nar/gkv031.
25.
WuS, ZhongG, ZhangJ, et al.A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge. Nature Communications. 2020; 11:4081. DOI: 10.1038/s41467-020-17972-1.
26.
HansraS, PujhariS, ZakhartchoukAN. Exploration of New Sites in Adenovirus Hexon for Foreign Peptides Insertion. The open virology journal. 2015; 9:1–6. DOI: 10.2174/1874357901509010001.
27.
ChampionHC, GeorgakopoulosD, HaldarS, et al.Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart: Application to study of phospholamban physiology. Circulation. 2003; 108:2790–2797. DOI: 10.1161/01.Cir.0000096487.88897.9b.
28.
SanjanaNE, ShalemO, ZhangF. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014; 11:783–784. DOI: 10.1038/nmeth.3047.
29.
BellCC, MagorGW, GillinderKR, et al.A high-throughput screening strategy for detecting CRISPR-Cas9 induced mutations using next-generation sequencing. BMC Genomics. 2014; 15:1002. DOI: 10.1186/1471-2164-15-1002.
30.
McConnellMJ, ImperialeMJ. Biology of adenovirus and its use as a vector for gene therapy. Hum Gene Ther. 2004; 15:1022–1033. DOI: 10.1089/hum.2004.15.1022.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
